Naturally Splendid (TSXV:NSP) announced through its recently acquired POS BPC facility in Saskatoon, Naturally Splendid Enterprises Ltd. has secured a government grant for HempOmega product development from the Saskatchewan Agri-Value Initiative (SAVI) under the Canada-Saskatchewan Growing Forward 2 bi-lateral agreement. The grant is an arrangement whereby Naturally Splendid and SAVI split the cost of the project 50/50 and Naturally Splendid will have 100% ownership of all data as well as information.
As quoted in the press release:

The product development project will be conducted at the Saskatchewan Food Industry Development Centre, Inc. (SFIDC) located in Saskatoon, Saskatchewan and is expected to run for up to three months with periodic reports and updates. The SFIDC is a non-profit organization, providing full service assistance to food processors wanting to add value to their products for domestic and/or international markets. The Food Centre’s expertise includes food and process development, interim processing and technology transfer.
The SFIDC has established a reputable role in food industry for R&D of new food concepts, interim processing, extrusion and food safety training. Since inception, the SFIDC has developed over 600 products with an estimated 50% introduced into the market. The staff boasts an impressive 125 plus years of experience in the food industry and several food scientists. The SFIDC houses a state-of-the-art federal facility that is HACCP Approved, Organic Certified, Canadian Food Inspection Agency (CFIA) approved for meat, dairy and processed foods, and FDA approved.
The product development specialists at SFIDC will be incorporating HempOmega® into various food applications to determine the maximum inclusion levels. The project will also evaluate shelf life and nutritional labeling to determine what levels are required to meet Health Canada’s Omega-3 nutrient claim. Potential markets for HempOmega™ include:
– Functional Foods / Supplements
– Nutraceutical Innovations
– Energy Drinks / Energy Bars
– Dairy / Dairy Alternatives
– Baked Goods
– Pet Foods & Livestock Feed
According to a recent Research and Markets report, the global omega-3 ingredients market was valued at US $2,786.2 million in 2014 and is expected to reach US $7,499.4 million by 2021. The health benefits of omega fatty acid consumption are being recognized globally and demand is increasing rapidly. As consumers continue to shift towards more sustainable and environmentally friendly diets, NSE is posed to capture a large share of this market with HempOmega®. HempOmega® is a microencapsulated hemp seed oil that has been formulated into a soluble, homogenous powder. Hemp seed oil is a great source of omega fatty acids and contains an ideal ratio of omega-6 to omega-3 as recommended by the World Health Organization.

Naturally Splendid CEO Craig Goodwin stated:

We are very excited about the HempOmega® evaluation project underway at SFIDC. This is a crucial next step in bringing HempOmega® to additional markets as a value-added omega nutritional ingredient. We already know that HempOmega® has shown superior bioavailability and sustainability of omega fatty acids and with the data from this project, we will understand how to incorporate it into a wide range of food products. Programs such as SAVI support our continued mission of becoming a leading provider of value-added, plant-based nutritional ingredient solutions. We thank SAVI for their support.

Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Kit

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less